Elsevier

Surgery

Volume 168, Issue 4, October 2020, Pages 643-652
Surgery

Liver
Artificial neural network model for preoperative prediction of severe liver failure after hemihepatectomy in patients with hepatocellular carcinoma

https://doi.org/10.1016/j.surg.2020.06.031Get rights and content

Abstract

Background

Posthepatectomy liver failure is a worrisome complication after major hepatectomy for hepatocellular carcinoma and is the leading cause of postoperative mortality. Recommendations for hepatectomy for hepatocellular carcinoma are based on the risk of severe posthepatectomy liver failure, and accurately predicting posthepatectomy liver failure risk before undertaking major hepatectomy is of great significance. Thus, herein, we aimed to establish and validate an artificial neural network model to predict severe posthepatectomy liver failure in patients with hepatocellular carcinoma who underwent hemihepatectomy.

Methods

Three hundred and fifty-three patients who underwent hemihepatectomy for hepatocellular carcinoma were included. We randomly divided the patients into a development set (n = 265, 75%) and a validation set (n = 88, 25%). Multivariate logistic analysis facilitated identification of independent variables that we incorporated into the artificial neural network model to predict severe posthepatectomy liver failure in the development set and then verified in the validation set.

Results

The morbidity of patients with severe posthepatectomy liver failure in the development and validation sets was 24.9% and 23.9%, respectively. Multivariate analysis revealed that platelet count, prothrombin time, total bilirubin, aspartate aminotransferase, and standardized future liver remnant were all significant predictors of severe posthepatectomy liver failure. Incorporating these factors, the artificial neural network model showed satisfactory area under the receiver operating characteristic curve for the development set of 0.880 (95% confidence interval, 0.836–0.925) and for the validation set of 0.876 (95% confidence interval, 0.801–0.950) in predicting severe posthepatectomy liver failure and achieved well-fitted calibration ability. The predictive performance of the artificial neural network model for severe posthepatectomy liver failure outperformed the traditional logistic regression model and commonly used scoring systems. Moreover, stratification into 3 risk groups highlighted significant differences between the incidences and grades of posthepatectomy liver failure.

Conclusion

The artificial neural network model accurately predicted the risk of severe posthepatectomy liver failure in patients with hepatocellular carcinoma who underwent hemihepatectomy. Our artificial neural network model might help surgeons identify intermediate and high-risk patients to facilitate earlier interventions.

Introduction

Globally, hepatocellular carcinoma (HCC) is the sixth most common form of cancer and the fourth leading cause of cancer related death.1 Major hepatectomy is the main type of radical therapy used for the treatment of HCC patients with extensive invasion into liver tissues.2, 3, 4 Although advances in surgical techniques for liver resection and perioperative care have greatly improved prognoses and treatment outcomes, posthepatectomy liver failure (PHLF) is a worrisome complication after major hepatectomy and is the leading cause of postoperative mortality.5, 6, 7, 8, 9 In addition, PHLF is the major cause of prolonged hospital stays, increased costs to patients and hospitals, and decreased long-term prognosis for HCC patients who have undergone hepatcetomy.7 Currently, techniques to help reduce the morbidity and mortality of PHLF are urgently needed by concerned hepatobiliary surgeons. One essential step to facilitate these needs and avoid PHLF and postoperative mortality is to increase the accuracy of preoperative assessments of liver functional reserve, particularly for HCC patients with potential impairment of hepatic function.

Generally, the development of PHLF is mainly determined by both the quality and quantity of hepatocytes after hepatectomy.10 Currently, there are many commonly used scoring systems for the determination of the quality of the liver, including (1) Child-Pugh grade,11,12 (2) model for end-stage liver disease (MELD),13 (3) albumin-bilirubin (ALBI),14,15 (4) platelet-albumin-bilirubin (PALBI),16,17 (5) fibrosis index based on the 4 factor (FIB-4),18,19 and (6) the aspartate aminotransferase to platelet ratio index (APRI) scoring system.20, 21, 22 However, these scoring systems are based on clinical symptoms and blood tests and do not take into consideration a number of certain important components of the liver and associated tissue such that many limitations have been revealed.11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22 For example, the Child-Pugh grade scoring system includes subjective criteria such as for ascites and hepatic encephalopathy, ultimately limiting its ability to predict early complications from posthepatectomy.11,12 The MELD scoring system was designed for patients with advanced cirrhosis and is inappropriate for most HCC patients.13 The ALBI and PALBI scoring systems failed to eliminate the “ceiling effect” of hyperbilirubinemia and hypoproteinemia on liver function assessment.14, 15, 16, 17 The FIB-4 and APRI scoring systems have mainly been used as noninvasive diagnostic tools for the assessment of fibrosis and cirrhosis; however, they require additional study to fully elucidate their impacts on liver quality.18, 19, 20, 21, 22 Moreover, indocyanine green retention test at 15 minutes (ICG-R15) is another tool that has been feasibly used to evaluate liver quality, but it is mainly used in Japan and is not as well accepted in other countries.23,24 Therefore, these liver function assessment methods, when used alone, may not be reliable for the accurate prediction of PHLF.

Based around recent efforts, many studies have confirmed that computed tomography (CT) volumetric imaging could be used to effectively assess liver functional reserve and that this may be especially useful for patients with HCC who underwent major hepatectomy.25,26 Future liver remnant (FLR) volume has also been used to calculate using 3 dimensional CT reconstruction technology, and may be effectively indicate the quantity of remnant liver after resection25,26; whereby, the lower the FLR value the higher the risk of serious complications after surgery.27,28 Nevertheless, FLR volume measurements did not exactly assess the quality of the hepatic parenchyma; therefore, this measure is not appropriate for assessing PHLF risk in HCC patients with damaged livers.29,30 Therefore, the FLR volume measurements should be combined with methods that facilitate evaluations of liver function to improve ability to predict severe PHLF.

Owing to the lack of a specific and practical model for predicting the risk of severe PHLF, development of a clinically applied model that combines both the quality and quantity of the FLR becomes desirable. Among all presently available methods, artificial neural network (ANN) models are mathematical tools that effectively imitate the structure of biological neural networks.31 ANN models possess the features including parallel-distributed data storage and data processing, good fault-tolerance, the ability to deal with high levels of non-linearity, are strongly self-adaptive, are self-organizing, and have self-learning abilities.31 Of the many types of assessments of disease risk, ANN models have proven to be more effective than traditional discriminant analysis and as such have become an often used alternative model and in some cases become a new standard.32,33 Nevertheless, thus far little research has examined the efficacy of use of ANN models for patients afflicted with HCC. Therefore, we sought to develop and assess the accuracy and reliability of a novel ANN model that would combine information for the quality and quantity of hepatocytes to predict preoperative individualized risk of severe PHLF for patients with HCC who underwent hemihepatectomy. Further, we sought to compare the discriminative ability of the ANN model with results from traditionally oriented logistic regression (LR) and commonly used scoring systems.

Section snippets

Patient population

Between September 2013 and June 2019, data for consecutive patients with HCC who underwent hemihepatectomy at the Guangxi Medical University Cancer Hospital were considered for inclusion. Our approach was retrospective and prospective, and the institutional review boards of our research center approved the components of this study. Inclusion eligibility criteria were as follows: (1) preoperative Child-Pugh grade A or B, (2) underwent initial hemihepatectomy, and (3) confirmed HCC by

Baseline characteristics

Detailed baseline characteristics for the training and validation sets are presented in Supplemental Table I. The mean age of the patient population was 48 ± 11 years and included 307 men and 46 women. The majority of patients (83.9%) had hepatitis B virus infection, 43.3% had cirrhosis, and 5.4% had clinically significant portal hypertension. Hepatic function was preserved in the majority of patients, with only 36 patients (10.2%) classified as Child-Pugh B; the median MELD score was 5 (2, 7);

Discussion

We successfully established and validated an ANN model used to predict severe PHLF in HCC patients preceding liver resection. The ANN model showed good predictive ability in both the development set (AUC: 0.880, 95% CI: 0.836–0.925) and validation set (AUC: 0.876, 95% CI: 0.801–0.950) and achieved well-fitted calibration abilities. Meanwhile, compared with the traditionally oriented LR model and commonly used scoring systems, the ANN model had significantly better predictive capabilities. In

Funding/Support

The study was supported by the National Science Foundation of China Youth Fund Project (81803007); the regional science fund project of the National Natural Science Foundation of China (81660498), the 66th Chinese Post-Doctoral Science Foundation Project (2019M663412), the Project of GuangXi Natural Science Foundation (2019JJA140151), the Key Research and Development Plan of Guangxi (Gui Ke AB16380242), the Youth Talent Fund Project of Guangxi Natural Science Foundation (Nos. 2018GXNSFBA281030

Conflicts of interest/Disclosure

The authors declare no conflict of interest.

References (44)

  • F. Bray et al.

    Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

    CA Cancer J Clin

    (2018)
  • J.K. Heimbach et al.

    AASLD guidelines for the treatment of hepatocellular carcinoma

    Hepatology

    (2018)
  • M. Omata et al.

    Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update

    Hepatol Int

    (2017)
  • European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

    J Hepatol

    (2018)
  • S. Balzan et al.

    The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy

    Ann Surg

    (2005)
  • R.T. Poon et al.

    Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database

    Ann Surg

    (2004)
  • A.C. Wei et al.

    Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma

    Br J Surg

    (2003)
  • K.P. Cieslak et al.

    New perspectives in the assessment of future remnant liver

    Dig Surg

    (2014)
  • F. Durand et al.

    Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD

    J Hepatol

    (2005)
  • R.N. Pugh et al.

    Transection of the oesophagus for bleeding oesophageal varices

    Br J Surg

    (1973)
  • M. Malinchoc et al.

    A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

    Hepatology

    (2000)
  • P.J. Johnson et al.

    Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade

    J Clin Oncol

    (2015)
  • Cited by (35)

    • A systematic review of prediction models for post-hepatectomy liver failure in patients undergoing liver surgery

      2021, HPB
      Citation Excerpt :

      Initially, a total of 1327 studies were screened from irrespective databases (Fig. 1). According to the study criteria, 28 studies were included in this systematic review.15–42 Table 1 shows a summary of these studies.

    View all citing articles on Scopus

    Rong-yun Mai and Hua-ze Lu contributed equally to this work.

    RYM, LQL, and JZY conceived the study and revised the manuscript critically for important intellectual content. RYM, HZL, and TB made significant contributions to its design, acquisition, analyses, and interpretation of data. RL, YL, LM, BDX, and GBW participated in the design, acquisition, analyses, and interpretation of information. All authors read and approved the final manuscript.

    View full text